Renal rupture associated with a poorly differentiated follicular thyroid carcinoma metastasizing to the thigh muscle, lung and kidney

Internal Medicine

Volumn 44, Issue 8, 2005, Pages 848-852

  Iwai, Hiroshi ^a   Ohno, Yasuhiro ^a   Ito, Hiroyuki ^a   Kiyokawa, Tomomi ^a   Aoki, Norihiko ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Distant metastases; Follicular thyroid carcinoma; p53 antibody; Renal rupture

Indexed keywords

ALFACALCIDOL; CALCIUM LACTATE; LEVOTHYROXINE; THYROGLOBULIN;

AGED; ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; KIDNEY METASTASIS; KIDNEY RUPTURE; LUNG BIOPSY; LUNG METASTASIS; MUSCLE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; THYROID CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION; TUMOR VOLUME; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; AGED; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MUSCLE NEOPLASMS; RUPTURE, SPONTANEOUS; THIGH; THYROID NEOPLASMS; TIME FACTORS;

EID: 24644497693     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.848     Document Type: Article

References (17)

1. Schlumberger MJ, Filetti S, Hay ID. Nontoxic goitor and thyroid neoplasia. In: Williams Textbook of Endocrinology, 10th ed., Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, Eds. WB Saunders, Philadelphia, PA, 457-490: 2002.
2. Mazzaferrri EL. Radioiodine and other treatment and outcomes. In: The Thyroid. Braverman LE., Utiger RD, (Eds.), Lippincott Williams & Wilkins, Philadelphia, PA, USA, 904-929: 2000.
3. Mazzaferrri EL. Thyroid carcinoma: papillary and follicular. In: Endocrine Tumors. Mazzaferri EL., Samaan N, Eds. Blackwell, Cambridge, England, 1993: 278.
4. Mizukami Y, Michigishi T, Nonomura A, et al. Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study. Hum Pathol 21: 283-290, 1990.
5. Takano T, Amino N. Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis. Endocr J 49: 97-107, 2002.
6. Takano T, Hasegawa Y, Miyauchi A, et al. Quantitative analysis of osteonectin mRNA in thyroid carcinomas. Endocr J 49: 511-516, 2002.
7. Schlumberger MJ, Caillou B. Miscellaneous tumors of the thyroid. In: The Thyroid. Braverman LE., Utiger RD, Eds. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 944-948: 2000.
8. Obara T. Anaplastic carcinoma. In: A treatment manual for thyroid disease. Takami H, Mori M, Eds. Nankodo, Tokyo, 1998: 95-99.
9. Tsutsui K. Thyroid anaplastic carcinoma: chemotherapy. Naibunpitsu Geka (Endocrine Surg) 16: 37-43, 1999 (in Japanese).
10. Ain KB, Egorin MJ, DeSimone PA. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trails (CATCHIT) Group. Thyroid 10: 587-594, 2000.
11. Kobayashi T, Asakawa H, Umeshita K, et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 18: 36-41, 1996.
12. Iwai H, Ohno Y, Aoki N. Thyroid anaplastic carcinoma with humoral hypercalcemia of malignancy (HHM): an autopsy case report. Endocr J 51: 303-310, 2004.
13. Farid NR, Shi Y, Zou M. Molecular basis of thyroid cancer. Endocr Rev 15: 202-232, 1994.
14. Nishiyama RH, Dunn EL, Thompson NW. Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer 30: 113-127, 1972.
15. Ito T, Seyama T, Mizuno T, et al. Genetic alterations in thyroid tumor progression: association with p53 gene mutations. Jpn J Cancer Res 84: 526-531, 1993.
16. Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid. A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231: 329-338, 2000.
17. Dobashi Y, Sakamoto A, Sugimura H, et al. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17: 375-381, 1993.